Quality Care
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
Selected early versions will be slated for real-world deployment.
HIMSS25
Dr. Sarah Hoffe, interim GI oncology chair at Moffitt Cancer Center, says telemedicine platforms and other technologies help ease nurse burnout, boost patient adherence and enable focused, personalized patient connections.
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
NUS Medicine’s latest model has outperformed DNA-based biological ageing clocks and demonstrated a stronger capability to predict mortality.
Intermountain Health plans to deploy Layer Health's AI platform across its network, which includes 33 hospitals in multiple states.